Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.45 | 4e-43 |
mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.28 | 2e-18 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.38 | 2e-17 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.4 | 4e-15 |
mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-14 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.35 | 1e-11 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.32 | 4e-09 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-08 |
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-07 |